EUVIMEDDescoperă EUVIMED
FallberichtOpen access · CC BY 4.0

Acral Mesenchymal Spindle Cell Neoplasm With a Novel HMGA2::NCOA2 Fusion

Grace Z Armstrong iD, Carina A Dehner iD, Eitan Halper-Stromberg, Esther Baranov, Anna C Eden, Rachel P Kowal iD

Journal of Cutaneous Pathology · 2025

DOI: 10.1111/cup.70041 ↗

At a glance

Fallbericht in Journal of Cutaneous Pathology, 2025. Written by Grace Z Armstrong and 5 co-authors. Institution: Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. Major MEDLINE topics: HMGA2 Protein, Nuclear Receptor Coactivator 2, Skin Neoplasms, Oncogene Proteins, Fusion. 31 references. The full text is freely available (open access, CC BY 4.0).

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Molecular profiling has revolutionized the field of soft tissue pathology, enhancing diagnostic precision and treatment strategies. The integration of molecular analysis and immunohistochemistry has been crucial for classifying diagnostically challenging acral mesenchymal neoplasms. Herein, we report the first documented case of an acral mesenchymal spindle cell neoplasm harboring an HMGA2::NCOA2 fusion. The neoplasm presented as a slow‐growing verrucous papule on the right thumb of an 18‐year‐old female. Histological examination revealed spindled cells of varying cellularity with intervening sclerotic collagen and dilated vasculature. The cells had patchy S100 and focal GLUT‐1 reactivity but were negative for CD34, EMA, Sox‐10, Pan‐TRK, p63, CKAE1/3, MUC4, ALK, Factor 13A, actin, desmin, and ERG. Given the unusual morphology and non‐diagnostic immunohistochemical profile, the specimen was sent for additional molecular profiling. Next‐generation sequencing revealed a novel in‐frame HMGA2 :: NCOA2 fusion. The tumor was likely benign, with 4 mitoses per 10 high‐powered fields (HPF), but was excised due to the unpredictable behavior of the fusion. As the first known case to date with this fusion, these findings contribute to the emerging research on genomic testing in acral soft tissue tumors. Additional cases and longer clinical follow‐up are needed to better characterize the novel HMGA2::NCOA2 fusion.

Subjects

MeSH terms (MEDLINE)

HMGA2 ProteinNuclear Receptor Coactivator 2Skin NeoplasmsOncogene Proteins, FusionSoft Tissue NeoplasmsHumansFemaleAdolescent

Author keywords

HMGA2NCOA2mesenchymal tumor

Substances

HMGA2 ProteinNCOA2 protein, humanHMGA2 protein, humanNuclear Receptor Coactivator 2Oncogene Proteins, Fusion

Authors and institutions

  • Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Dermatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

ORCID profiles: Grace Z Armstrong, Carina A Dehner, Rachel P Kowal

Cite

APA

Armstrong, G. Z., Dehner, C. A., Halper-Stromberg, E., Baranov, E., Eden, A. C., & Kowal, R. P. (2025). Acral Mesenchymal Spindle Cell Neoplasm With a Novel HMGA2::NCOA2 Fusion. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.70041

Vancouver

Armstrong GZ, Dehner CA, Halper-Stromberg E, Baranov E, Eden AC, Kowal RP. Acral Mesenchymal Spindle Cell Neoplasm With a Novel HMGA2::NCOA2 Fusion. Journal of Cutaneous Pathology. 2025. doi:10.1111/cup.70041

BibTeX
@article{Armstrong2025,
  author = {Armstrong, Grace Z and Dehner, Carina A and Halper-Stromberg, Eitan and Baranov, Esther and Eden, Anna C and Kowal, Rachel P},
  title = {Acral Mesenchymal Spindle Cell Neoplasm With a Novel HMGA2::NCOA2 Fusion},
  journal = {Journal of Cutaneous Pathology},
  year = {2025},
  doi = {10.1111/cup.70041}
}
Start for free →